p27kip1 in intestinal turmorigenesis and chemoprevention in the mouse

WanCai Yang, Laura Bancroft, Jiao Liang, Min Zhuang, Leonard H. Augenlicht

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Targeted inactivation of p27kip1 was sufficient for intestinal tumor formation in mice, but this was strictly a function of diet: tumors formed in p27+/- or p27-/- mice fed control AIN-76A diet and were increased by a western-style diet but did not develop in mice fed standard chow diet. When crossed with the Apc1638N+/- mouse, Apc +/-, p27+/- or Apc+/-, p27-/- mice not only formed twice as many tumors than the sum of the tumors from mutation at either locus alone, but on AIN76A diet also developed intestinal intussusception, a tumor-associated pathology in patients leading to intestinal blockage that lias not been reported for intestinal cancer in mouse models. Moreover, the frequency of intussusception was increased when the compound mutant mice were maintained on the western diet, leading to early death. Despite this more aggressive tumor phenotype generated by inactivation of p27 than by inactivation of another cyclin-dependent kinase inhibitor, p21 WAF1/cip1, the nonsteroidal anti-inflammatory drug sulindac was still effective in inhibiting intestinal tumor formation in Apc+/-, p27+/- or Apc+/-,p27-/- mice, which contrasts with the abrogation of the effects of sulindac in Apc+/-,p21 +/- or Apc+/-,p21-/- mice, indicating that p27 is not necessary for tumor inhibition by sulindac. Furthermore, tumor inhibition by sulindac was linked to the induction of p21 expression by the drug, regardless of p27 status, leading to suppression of cell proliferation and promotion of cell differentiation and apoptosis in the intestinal mucosa.

Original languageEnglish (US)
Pages (from-to)9363-9368
Number of pages6
JournalCancer Research
Volume65
Issue number20
DOIs
StatePublished - Oct 15 2005

Fingerprint

Chemoprevention
Sulindac
Neoplasms
Diet
Intussusception
Cyclin-Dependent Kinase Inhibitor p21
Intestinal Neoplasms
Intestinal Mucosa
Pharmaceutical Preparations
Cell Differentiation
Anti-Inflammatory Agents
Cell Proliferation
Apoptosis
Pathology
Phenotype
Mutation

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

p27kip1 in intestinal turmorigenesis and chemoprevention in the mouse. / Yang, WanCai; Bancroft, Laura; Liang, Jiao; Zhuang, Min; Augenlicht, Leonard H.

In: Cancer Research, Vol. 65, No. 20, 15.10.2005, p. 9363-9368.

Research output: Contribution to journalArticle

Yang, WanCai ; Bancroft, Laura ; Liang, Jiao ; Zhuang, Min ; Augenlicht, Leonard H. / p27kip1 in intestinal turmorigenesis and chemoprevention in the mouse. In: Cancer Research. 2005 ; Vol. 65, No. 20. pp. 9363-9368.
@article{1eec95b2f3664bf6860c070d6ff8b8e4,
title = "p27kip1 in intestinal turmorigenesis and chemoprevention in the mouse",
abstract = "Targeted inactivation of p27kip1 was sufficient for intestinal tumor formation in mice, but this was strictly a function of diet: tumors formed in p27+/- or p27-/- mice fed control AIN-76A diet and were increased by a western-style diet but did not develop in mice fed standard chow diet. When crossed with the Apc1638N+/- mouse, Apc +/-, p27+/- or Apc+/-, p27-/- mice not only formed twice as many tumors than the sum of the tumors from mutation at either locus alone, but on AIN76A diet also developed intestinal intussusception, a tumor-associated pathology in patients leading to intestinal blockage that lias not been reported for intestinal cancer in mouse models. Moreover, the frequency of intussusception was increased when the compound mutant mice were maintained on the western diet, leading to early death. Despite this more aggressive tumor phenotype generated by inactivation of p27 than by inactivation of another cyclin-dependent kinase inhibitor, p21 WAF1/cip1, the nonsteroidal anti-inflammatory drug sulindac was still effective in inhibiting intestinal tumor formation in Apc+/-, p27+/- or Apc+/-,p27-/- mice, which contrasts with the abrogation of the effects of sulindac in Apc+/-,p21 +/- or Apc+/-,p21-/- mice, indicating that p27 is not necessary for tumor inhibition by sulindac. Furthermore, tumor inhibition by sulindac was linked to the induction of p21 expression by the drug, regardless of p27 status, leading to suppression of cell proliferation and promotion of cell differentiation and apoptosis in the intestinal mucosa.",
author = "WanCai Yang and Laura Bancroft and Jiao Liang and Min Zhuang and Augenlicht, {Leonard H.}",
year = "2005",
month = "10",
day = "15",
doi = "10.1158/0008-5472.CAN-05-2113",
language = "English (US)",
volume = "65",
pages = "9363--9368",
journal = "Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "20",

}

TY - JOUR

T1 - p27kip1 in intestinal turmorigenesis and chemoprevention in the mouse

AU - Yang, WanCai

AU - Bancroft, Laura

AU - Liang, Jiao

AU - Zhuang, Min

AU - Augenlicht, Leonard H.

PY - 2005/10/15

Y1 - 2005/10/15

N2 - Targeted inactivation of p27kip1 was sufficient for intestinal tumor formation in mice, but this was strictly a function of diet: tumors formed in p27+/- or p27-/- mice fed control AIN-76A diet and were increased by a western-style diet but did not develop in mice fed standard chow diet. When crossed with the Apc1638N+/- mouse, Apc +/-, p27+/- or Apc+/-, p27-/- mice not only formed twice as many tumors than the sum of the tumors from mutation at either locus alone, but on AIN76A diet also developed intestinal intussusception, a tumor-associated pathology in patients leading to intestinal blockage that lias not been reported for intestinal cancer in mouse models. Moreover, the frequency of intussusception was increased when the compound mutant mice were maintained on the western diet, leading to early death. Despite this more aggressive tumor phenotype generated by inactivation of p27 than by inactivation of another cyclin-dependent kinase inhibitor, p21 WAF1/cip1, the nonsteroidal anti-inflammatory drug sulindac was still effective in inhibiting intestinal tumor formation in Apc+/-, p27+/- or Apc+/-,p27-/- mice, which contrasts with the abrogation of the effects of sulindac in Apc+/-,p21 +/- or Apc+/-,p21-/- mice, indicating that p27 is not necessary for tumor inhibition by sulindac. Furthermore, tumor inhibition by sulindac was linked to the induction of p21 expression by the drug, regardless of p27 status, leading to suppression of cell proliferation and promotion of cell differentiation and apoptosis in the intestinal mucosa.

AB - Targeted inactivation of p27kip1 was sufficient for intestinal tumor formation in mice, but this was strictly a function of diet: tumors formed in p27+/- or p27-/- mice fed control AIN-76A diet and were increased by a western-style diet but did not develop in mice fed standard chow diet. When crossed with the Apc1638N+/- mouse, Apc +/-, p27+/- or Apc+/-, p27-/- mice not only formed twice as many tumors than the sum of the tumors from mutation at either locus alone, but on AIN76A diet also developed intestinal intussusception, a tumor-associated pathology in patients leading to intestinal blockage that lias not been reported for intestinal cancer in mouse models. Moreover, the frequency of intussusception was increased when the compound mutant mice were maintained on the western diet, leading to early death. Despite this more aggressive tumor phenotype generated by inactivation of p27 than by inactivation of another cyclin-dependent kinase inhibitor, p21 WAF1/cip1, the nonsteroidal anti-inflammatory drug sulindac was still effective in inhibiting intestinal tumor formation in Apc+/-, p27+/- or Apc+/-,p27-/- mice, which contrasts with the abrogation of the effects of sulindac in Apc+/-,p21 +/- or Apc+/-,p21-/- mice, indicating that p27 is not necessary for tumor inhibition by sulindac. Furthermore, tumor inhibition by sulindac was linked to the induction of p21 expression by the drug, regardless of p27 status, leading to suppression of cell proliferation and promotion of cell differentiation and apoptosis in the intestinal mucosa.

UR - http://www.scopus.com/inward/record.url?scp=27144529070&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=27144529070&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-05-2113

DO - 10.1158/0008-5472.CAN-05-2113

M3 - Article

C2 - 16230399

AN - SCOPUS:27144529070

VL - 65

SP - 9363

EP - 9368

JO - Cancer Research

JF - Cancer Research

SN - 0008-5472

IS - 20

ER -